References Glucagon-like peptide 1-based therapies for the treatment of type 2 diabetes mellitus UpToDate accessed 5/11/24 GLP-1 receptor agonists | Prescribing information | Diabetes type 2 | CKS | NICE Bydureon 2 mg prolonged release suspension for injection in pre-filled pen (BCise) Summary of Product Characteristics (SmPC) (emc) Victoza 6 mg/ml solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) TRULICITY 1.5 mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) Ozempic 0.25 mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) Mounjaro KwikPen 10mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc)
Sassoon DJ, Tune JD, Mather KJ, Noblet JN, Eagleson MA, Conteh AM, Sturek JT, Goodwill AG
(NIDDK) Brain pathways involved in hunger and cravings are altered in a way that reduces appetite
It is wise to minimise: Sugary drinks such as soft drinks, energy drinks, sweetened coffees and juices Refined carbohydrates such as white bread, pastries and many packaged cereals Ultra processed snacks such as chips, lollies and biscuits Very fatty or fried foods that can aggravate nausea and slow digestion further Large heavy meals , especially late at night Excess alcohol , which can affect blood sugar and gut health If you are experiencing reflux, nausea or bloating, your practitioner may also suggest limiting very spicy foods, carbonated drinks and high fat takeaway meals
If peptides are on your roadmap, do you have specialized counsel and a plan that can adapt to a single regulatory decision